George W Sledge

发表

Making Personalized Cancer Medicine a Reality: Challenges and Opportunities in the Development of Biomarkers and Companion Diagnostics

David R Parkinson, Bruce E Johnson, G. Sledge, 2012, Clinical Cancer Research.

Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features.

Robert Gray, Sunil Badve, Edith A Perez, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Targeted Therapy for Cancer in the Genomic Era.

G. Sledge, George W Sledge, Anosheh Afghahi, 2015, Cancer journal.

C-MYC alterations and association with patient outcome in early-stage HER2-positive breast cancer from the north central cancer treatment group N9831 adjuvant trastuzumab trial.

Peter A Kaufman, Lyndsay N Harris, James N Ingle, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CancerLinQ and the future of cancer care.

Robert Hauser, G. Sledge, Robert S. Miller, 2013, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Heterogeneity and cancer.

G. Sledge, K. Allison, George W Sledge, 2014, Oncology.

Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model

Liang Cheng, Gary D Hutchins, Qi-Huang Zheng, 2006, The Prostate.

Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory.

Edith A Perez, E. Perez, S. Martino, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients

Harikrishna Nakshatri, Sunil Badve, Yunlong Liu, 2011, Breast Cancer Research.

Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group n9831 Adjuvant Trastuzumab Trial.

Krishna R. Kalari, Jeanette E Eckel-Passow, Krishna R Kalari, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles.

Yehia Mechref, Milos V Novotny, Y. Mechref, 2008, Clinical chemistry.

Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.

Virginia G Kaklamani, Soonmyung Paik, Matthew P Goetz, 2019, The New England journal of medicine.

Synthesis and preliminary biological evaluation of new carbon-11 labeled tetrahydroisoquinoline derivatives as SERM radioligands for PET imaging of ER expression in breast cancer.

Min Wang, Qi-Huang Zheng, G. Sledge, 2008, European journal of medicinal chemistry.

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.

Robert B Livingston, Lois Shepherd, James N Ingle, 2010, The Lancet. Oncology.

Adjuvant Chemotherapy Guided by a 21‐Gene Expression Assay in Breast Cancer

Virginia G Kaklamani, Soonmyung Paik, Matthew P Goetz, 2018, The New England journal of medicine.

Optimization of RNA extraction from FFPE tissues for expression profiling in the DASL assay.

Brian Leyland-Jones, G. Sledge, B. Leyland-Jones, 2008, BioTechniques.

What is targeted therapy?

G. Sledge, George W Sledge, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Wnt signaling in triple negative breast cancer is associated with metastasis

Pradip De, G. Sledge, B. Leyland-Jones, 2013, BMC Cancer.

A Physiologic Imaging Pilot Study of Breast Cancer Treated with AZD2171

Gary D Hutchins, Qi-Huang Zheng, Sunil Badve, 2006, Clinical Cancer Research.

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.

Virginia G Kaklamani, Soonmyung Paik, Ingrid A Mayer, 2015, The New England journal of medicine.

The role of angiogenesis inhibition in the treatment of breast cancer.

G. Sledge, H. Rugo, H. Burstein, 2006, Clinical advances in hematology & oncology : H&O.

Past, present, and future challenges in breast cancer treatment.

G. Hortobagyi, G. Sledge, A. Wolff, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial.

Karen A Gelmon, James N Ingle, Vered Stearns, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lessons learned from the development of the CancerLinQ prototype: Clinical decision support.

Peter Paul Yu, Robert Hauser, Allen S Lichter, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.